The response effect of pheochromocytoma (PC12) cell lines to oxidized multi-walled carbon nanotubes (o-MWCMTs).

BACKGROUND: The applications of oxidized carbon nanotubes (o-CNTs) have shown potentials in novel drug delivery including the brain which is usually a challenge. This underscores the importance to study its potential toxic effect in animals. Despite being a promising tool for biomedical applications little is known about the safety of drugs in treating brain diseases. The toxicity of oxidized multi-walled carbon nanotubes (o-MWCNTs) are of utmost concern and in most in-vitro studies conducted so far are on dendritic cell (DC) lines with limited data on PC12 cell lines. OBJECTIVES: We focused on the effect of o-MWCNTs in PC12 cells in vitro: a common model cell for neurotoxicity. METHODS: The pristine multi-walled carbon nanotubes (p-MWCNTs) were produced by the swirled floating catalytic chemical vapour deposition method (SFCCVD). The p-MWCNTs were then oxidized using purified H2SO4/HNO3 (3:1v/v) and 30% HNO3 acids to produce o-MWCNTs. The Brunauer-Emmett-Teller (BET), transmission electron microscopy (TEM), Scanning electron microscopy (SEM), thermogravimetric analyser (TGA) and Raman spectroscopy techniques were used to characterize the MWCNTs. The PC12 cells were cultured in RPMI medium containing concentrations of o-MWCNTs ranging from 50 to 200 µg/ml. RESULTS: The o-MWCNTs demonstrated slight cytotoxicity at short time period to PC12 neuronal cells whilst at longer time period, no significant (p > 0.05) toxicity was observed due to cell recovery. CONCLUSION: In conclusion, the o-MWCNTs did not affect the growth rate and viability of the PC12 cells due to lack of considerable toxicity in the cells during the observed time period but further investigations are required to determine cell recovery mechanism.

Process synthesis and optimization for the production of carbon nanostructures.

A swirled fluidized bed chemical vapour deposition (SFCVD) reactor has been manufactured and optimized to produce carbon nanostructures on a continuous basis using in situ formation of floating catalyst particles by thermal decomposition of organometallic ferrocene. During the process optimization, carbon nanoballs were produced in the absence of a catalyst at temperatures higher than 1000 degrees C, while carbon nanofibres, single-walled carbon nanotubes, helical carbon nanotubes, multi-walled carbon nanotubes (MWCNTs) and carbon nanofibres (CNFs) were produced in the presence of a catalyst at lower temperatures of between 750 and 900 degrees C. The optimum conditions for producing carbon nanostructures were a temperature of 850 degrees C, acetylene flow rate of 100 ml min(-1), and acetylene gas was used as the carbon source. All carbon nanostructures produced have morphologies and diameters ranging from 15 to 200 nm and wall thicknesses between 0.5 and 0.8 nm. In comparison to the quantity of MWCNTs produced with other methods described in the literature, the SFCVD technique was superior to floating catalytic CVD (horizontal fixed bed) and microwave CVD but inferior to rotary tube CVD.

Computational molecular modeling and structural rationalization for the design of a drug-loaded PLLA/PVA biopolymeric membrane.

The purpose of this study was to design, characterize and assess the influence of triethanolamine (TEA) on the physicomechanical properties and release of methotrexate (MTX) from a composite biopolymeric membrane. Conjugated poly(L-lactic acid) (PLLA) and poly(vinyl alcohol) (PVA) membranes were prepared by immersion precipitation with and without the addition of TEA. Drug entrapment efficiency (DEE) and release studies were performed in phosphate buffered saline (pH 7.4, 37 degrees C). Scanning electron microscopy elucidated the membrane surface morphology. Computational and structural molecular modeling rationalized the potential mechanisms of membrane formation and MTX release. Bi-axial force-distance (F-D) extensibility profiles were generated to determine the membrane toughness, elasticity and fracturability. Membranes were significantly toughened by the addition of TEA as a discrete rubbery phase within the co-polymer matrix. MTX-TEA-PLLA-PVA membranes were tougher (F = 89 N) and more extensible (D = 8.79 mm) compared to MTX-PLLA-PVA (F = 35 N, D = 3.7 mm) membranes as a greater force of extension and fracture distance were required (N = 10). DEE values were relatively high (>80%, N = 5) for both formulations. Photomicrographs revealed distinct crystalline layered morphologies with macro-pores. MTX was released by tri-phasic kinetics with a lower fractional release of MTX from MTX-TEA-PLLA-PVA membranes compared to MTX-PLLA-PVA. TEA provided a synergistic approach to improving the membrane physicomechanical properties and modulation of MTX release. The composite biopolymeric membrane may therefore be suitable for the novel delivery of MTX in the treatment of chronic primary central nervous system lymphoma.

Synthesis of carbon nanotubes by swirled floating catalyst chemical vapour deposition method.

A series of developments have been made in synthesizing Carbon Nanotubes (CNTs) by Catalytic Vapour Deposition (CVD) methods since its discovery as a possible route to the large scale and high quality production of CNTs. In this study, CNTs were synthesized continuously in a swirled floating catalytic chemical vapour deposition reactor using acetylene as carbon source, ferrocene as catalyst, with argon and hydrogen as carrier gases within the temperature range of 900-1050 degrees C. The effects of pyrolysis temperature, acetylene flow rate, hydrogen flow rate, and ratio of flow of acetylene to hydrogen on the rate of production of CNTs were investigated. The CNTs produced were purified with dilute nitric acid and the nature and quality of the CNTs were analysed by TEM, Raman spectrometer, EDX, and TGA. Results obtained revealed that a mixture of single and multi wall carbon nanotubes were produced continuously with a maximum yield rate of 0.31 g/min at 1000 degrees C and a flow ratio of acetylene to hydrogen of one to five.